Conference Presentation, Product Demonstration, Keynote
Dr. Ilya Burkov (Nebius): Powering Next‑Gen Biotech Research with High‑Performance AI and Cloud GPUs
- Nebius positions itself as a full-stack infrastructure provider aiming to resolve hyperscaler inflexibility and vendor lock-in, offering a vision of infinite capacity and availability.
- Strategic expansion plans include scaling throughput into the US, Asia, and the Middle East while maintaining headquarters within the European Union.
- The company targets customers in healthcare, biotech, and drug discovery by providing managed Kubernetes, managed Slurm, and tailored solutions for DStack and ML Ops toolkits.
- Operational models emphasize an "Uber approach" for GPU management, allowing for burst capacity usage for one to two months and offering both reserve and pay-as-you-go options without long-term contracts.
- Technical expectations include immediate access to latest NVIDIA GPUs, the ability to handle datasets and models with over 100 million parameters, and a projected 90% performance improvement compared to hyperscalers.
- Specific applications for 2025 include "Agentic AI" for reducing workload in European and Asian healthcare systems and AI tools to virtually screen medications for drug discovery.
- Market predictions suggest AI will exponentially reduce time to market and costs for pharmaceuticals, while acting as an assistant to radiologists rather than replacing them.
- The presenter plans a 20-minute discussion covering infrastructure, operations, case studies, and scientific work, followed by approximately five minutes for questions.